Article
Multi-Timepoint Risk Stratification in Rare Cancers: A Computational Framework Validated against Published Ewing Sarcoma Trial Data
2026-07-07
Abstract excerpt
Three audiences — the family of a newly diagnosed Ewing sarcoma patient, the long-term survivor, and the cooperative-group trial statistician — receive cohort-mean answers to patient-level questions because the patient-level data machine learning requires do not exist for rare cancers. We present a framework producing patient-level predictions from published aggregate trial data. A six-stage discrete-event Monte C...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 887b5abf-59f8-5304-8d73-4cc536b78f29
- DOI
- 10.64898/2026.07.03.26357236
